Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

HIMARS vs. MLRS: Which Rocket System Packs a Bigger Punch? – Part 1

Daniel Kim Views  

누가 셀까…고속기동 로켓 ‘HIMARS’ vs 다연장 로켓 ‘M270 MLRS’[이현호 기자의 밀리터리!톡]
The M270 MLRS is equipped with a total of 12 227mm rockets. Photo provided by = Defense Daily

When Russia invaded Ukraine two years ago, most expected Russia to win quickly. However, such predictions did not materialize. This is because, with the help of strong support from the West based on the Ukrainian military’s desperate resistance, Ukrainian weapons have caused significant damage to Russian troops, thwarting their advance. Among them, there is a weapon system that overturns early war predictions and changes the course of the war. It’s a long-range rocket system with outstanding range and destructive power.

The representative ones are the “M142 High Mobility Artillery Rocket System (HIMARS)” and the “M270 Multiple Launch Rocket System (MLRS).” These weapons are being highlighted as a significant threat to Russia and evaluated as “game changers” that can determine victory or defeat in terms of range and destructive power. The Ukrainian government, which has experienced this fact, is also persistently requesting support from the United States.

The Washington Post (WP) and other media have reported that “so far, HIMARS has destroyed over 200 targets.” In particular, it was reported that they are playing a significant role in reducing Ukrainian casualties by directly striking Russian artillery with the help of counter-battery radar, along with the M777 towed howitzer provided by the West, which has a maximum range of 40km.

To read Part 2…
To read Part 3…

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[DEBATE] Latest Stories

  • Model 3's Struggles: 1 in 4 Fail Safety Inspections in Denmark and Germany
  • Xiaomi’s Success vs. Apple’s Failure: What’s the Difference?
  • Trump Defends Tesla, Promises Action Against Violent Attacks
  • Ford's Bold Move: Will the Mustang Evolve into a Sedan with the Mach 4 Name?
  • Revival of the Estima? Toyota’s Sienna May Re-enter Japan's Market
  • Kia’s EV9 Recalled in the U.S. Over Powertrain Concerns

You May Also Like

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE 

Must-Reads

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE 

Share it on...